Xin Lu

机构：Shanghai Medical College of Fudan University, Chinese Academy of Medical Sciences & Peking Union Medical College, Fudan University, Peking Union Medical College Hospital, Soochow University, Hangzhou Quality and Technical Supervision and Testing Institute, Fudan University Shanghai Cancer Center, Laboratoire d’Imagerie Biomédicale, National Institute for Communicable Disease Control and Prevention, Changzhou No.2 People's Hospital, Fourth People's Hospital of Changzhou · ORCID：0000-0002-4951-6134

发表论文 163 篇 · 总被引 3532 次 · h-index 31

代表论文

• Evolutionary patterns and research frontiers in neoadjuvant immunotherapy: a bibliometric analysis (2023 · International Journal of Surgery · 被引 185)
• Single-cell profiling identifies IL1Bhi macrophages associated with inflammation in PD-1 inhibitor-induced inflammatory arthritis (2024 · Nature Communications · 被引 41)
• Regional antimicrobial resistance gene flow among the One Health sectors in China (2025 · Microbiome · 被引 37)
• MXene-based nanozymes remodel tumor microenvironment for heterojunction-enhanced sonodynamic and chemodynamic therapy to boost robust cancer immunotherapy (2024 · Chemical Engineering Journal · 被引 15)
• Iodine-131 radioembolization boosts the immune activation enhanced by icaritin/resiquimod in hepatocellular carcinoma (2024 · Journal of Controlled Release · 被引 11)
• 57O A phase I/II multicenter, first-in-human study of DB-1311/BNT324 (a novel B7H3 ADC) in patients with advanced solid tumors (2024 · Annals of Oncology · 被引 11)